IF you have ANY connection to the Canadian ministry of health, PLEASE think about helping this effort along…OTC DHEA and Pregnenolone would be a huge favour to Canadians and would save BILLIONS !
ABOUT THIS POST
I firmly believe that the ubiquitous deficiency of DHEA, from which the majority of our population suffers, is a millstone about the neck of the race, which is easily, and should be routinely, corrected by oral supplementation of DHEA.
The problem is neatly soved in the USA, where DHEA is inexpensive and OTC, but to date in Canada, it is on the DANGEROULS DRUGS LIST, along with Pregnenolone, which is almost as important to the health of ur population.
I have written to Canada’s minister of health, about the problem and now, so that the SUBSTACK community will have a “handle” on the question and perhaps, see fit to advertise the situation to “THOSE WHO CAN“, I have copied that letter below.
……………………………………………………………………………………………………………………………………
The Honourable Marjorie Michel,
Minister of Health Health Canada,
Address Locator 0900C2
Dear Minister Michel,
I am writing to respectfully request your consideration of a review of, and possible adjustment to, the regulatory status of dehydroepiandrosterone (DHEA) in Canada.
As a retired physician with clinical and academic experience in Urology (32 Years), Family practice (14 years) and Hormone Therapy (8 years), I have become increasingly concerned that age-related DHEA deficiency represents an under-recognized public-health issue affecting older Canadians. Current evidence indicates that physiological DHEA replacement supports healthy aging, improves quality of life, and reduces healthcare utilization in older adults.
The United States has permitted over-the-counter access to DHEA for more than three decades, without evidence of population-level harm, while Canada’s continued classification of DHEA as a prescription-only drug limits access to a safe, low-cost intervention with hugely meaningful public-health value.
I believe this issue aligns with the public health mantra: support evidence-based policy, promote healthy aging, and modernize regulatory frameworks where appropriate.
I would be grateful if your office would review this material and advise whether a meeting with a policy advisor or relevant official might be arranged. I would welcome the opportunity to discuss the matter further, entirely at your convenience and to provide any additional clinical or scientific information that may assist you, or your department.
Thank you for your attention to this important public-health consideration.
With my thanks for your continued service to Canada, and for your time, as related to this matter,
Truly,
Gervais Angelo Harry, MB,BS, LMCC, FRCSC, ABAARM (Retired).
Email gervaisharry222@gmail.com, Cell 415-473-1794,
WEBpage: gervaisharry.substack.com
PS My experience of DHEA deficiency in family practice is outlined in two posts to SUBSTACK:
DHEA DEFICIENCY in Family practice and DHEA DEFICIENCY in WOMEN :
I will gladly provide free access to those articles, should you, or your team, desire to assess them.
IF you have ANY connection to the Canadian ministry of health, PLEASE think about helping this effort along……. OTC DHEA and Pregnenolone would be a huge, safe favour to Canadians and would save the health system BILLIONS !